British Journal of Anaesthesia, Vol 81, Issue 4 540-543, Copyright © 1998 by The Board of Management and Trustees of the British Journal of Anaesthesia
S. Grant, S. Noble, A. Woods, J. Murdoch and A. Davidson
We have assessed intubating conditions in three groups of 60 ASA I or II
patients after induction of anaesthesia with propofol 2 mg kg-1 and
remifentanil 0.5, 1.0 or 2.0 micrograms kg-1. Tracheal intubation was
graded according to ease of laryn-goscopy, position of the vocal cords,
coughing, jaw relaxation and movement of the limbs. Intubation was
successful in 80%, 90% and 100% of patients after remifentanil 0.5, 1.0 or
2.0 micrograms kg-1, respectively. Overall intubating conditions were
regarded as acceptable in 20%, 50% and 80% of patients, respectively. All
three groups had a decrease in arterial pressure after induction but there
was no difference between groups. The decrease in arterial pressure was not
regarded as clinically significant. Intubating conditions were best after
induction with remifentanil 2 micrograms kg and propofol 2 mg kg-1.
CLINICAL INVESTIGATIONS
Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanil
Glasgow University Department of Anaesthesia, Glasgow Royal Infirmary, Alexandra Parade, Glasgow; Department of Anaesthesia, Victoria Infirmary, Langside Road, Glasgow
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. H. Lundstrom, A. M. Moller, C. Rosenstock, G. Astrup, M. R. Gatke, J. Wetterslev, and the Danish Anaesthesia Database Avoidance of neuromuscular blocking agents may increase the risk of difficult tracheal intubation: a cohort study of 103 812 consecutive adult patients recorded in the Danish Anaesthesia Database Br. J. Anaesth., August 1, 2009; 103(2): 283 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lallo, V. Billard, and J.-L. Bourgain A Comparison of Propofol and Remifentanil Target-Controlled Infusions to Facilitate Fiberoptic Nasotracheal Intubation Anesth. Analg., March 1, 2009; 108(3): 852 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Resche-Rigon, S. Zohar, and S. Chevret Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes Clinical Trials, December 1, 2008; 5(6): 595 - 606. [Abstract] [PDF] |
||||
![]() |
X. Combes, L. Andriamifidy, E. Dufresne, P. Suen, S. Sauvat, E. Scherrer, P. Feiss, J. Marty, and P. Duvaldestin Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort Br. J. Anaesth., August 1, 2007; 99(2): 276 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Crawford, J. Hayes, and J. M. Tan Dose-Response of Remifentanil for Tracheal Intubation in Infants Anesth. Analg., June 1, 2005; 100(6): 1599 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Woods and S. Allam Tracheal intubation without the use of neuromuscular blocking agents Br. J. Anaesth., February 1, 2005; 94(2): 150 - 158. [Full Text] [PDF] |
||||
![]() |
A.-M. Machata, C. Gonano, A. Holzer, D. Andel, C. K. Spiss, M. Zimpfer, and U. M. Illievich Awake Nasotracheal Fiberoptic Intubation: Patient Comfort, Intubating Conditions, and Hemodynamic Stability During Conscious Sedation with Remifentanil Anesth. Analg., September 1, 2003; 97(3): 904 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Durmus, G. Ender, B. A. Kadir, G. Nurcin, O. Erdogan, and M. O. Ersoy Remifentanil With Thiopental for Tracheal Intubation Without Muscle Relaxants Anesth. Analg., May 1, 2003; 96(5): 1336 - 1339. [Abstract] [Full Text] [PDF] |
||||


